Acorda Therapeutics reported $13K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acorda Therapeutics ACOR:US $ 0.01M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
ALKERMES ALKS:US $ 1.68M 0.02M
Amgen AMGN:US $ 31247M 849M
Anika Therapeutics ANIK:US $ 0.14M 0M
Aptinyx Inc APTX:US $ 677K 0
Arrowhead Research ARWR:US $ 198K 1000
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cara Therapeutics CARA:US $ 53K 0
Clovis Oncology CLVS:US $ 0.14M 0.02M
Cytokinetics CYTK:US $ 0.08M 0M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
Gilead Sciences GILD:US $ 1M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.19M 6K
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Mannkind MNKD:US $ 2.52M 0.01M
Merck MRK:GR € 565M 397M
Moderna Inc MRNA:US 40K 40K
Novartis NOVN:VX SF 901M 0M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M